Dr. Dmitry Kostyushev is the head of the Laboratory of Genetic Technologies at Sechenov University in Moscow, Russia. He has a Master’s degree from Sechenov University, a Doctorate and Post-Doctorate from the Central Research Institute of Epidemiology, and a Habilitation from the National Medical Research Center for Tuberculosis and Infectious Diseases. Dr. Kostyushev’s main research interests include using CRISPR/Cas systems to destroy the hepatitis B virus, as well as understanding the biology of hepatitis B and D viruses to identify new therapeutic targets. He is particularly interested in developing new techniques for packaging and delivering CRISPR/Cas systems in vivo.